Florida Physician Ebook Continuing Education - MDFL2626

43

COLORECTAL CANCER COURSE FOUR | 15 CREDIT HOURS

Colorectal cancer is the third leading cause of cancer death in the United States, and roughly 35% of those who develop colorectal cancer die from the disease. Improved therapies and widespread primary prevention through screening have resulted in the United States being the only developed country with declining colorectal cancer incidence and mortality. However, there is substantial room for improvement, and primary care provider knowledge of colorectal cancer is essential to continue reducing cases through screening and early detection. Improved clinician knowledge of the most recent research on new diagnostic and therapy modalities is required in order to improve patient outcomes and reduce side effects.

95

OSTEOPOROSIS: DIAGNOSIS AND MANAGEMENT COURSE FIVE | 5 CREDIT HOURS

Osteoporosis has increasingly become a major health problem. The National Institutes of Health (NIH) has estimated that more than 10 million Americans have osteoporosis and more than 44 million have low bone mass, or osteopenia, which places them at risk for osteoporosis. To effectively prevent, diagnose, and treat this disease, physicians and other healthcare providers should understand the epidemiology, physiology, and management of osteoporosis.

122 FINAL EXAMINATION ANSWER SHEET REQUIRED TO RECEIVE CREDIT

InforMed has the solution. Scan the QR code or go to https://uqr.to/deamate to get started. Effective June 27, 2023 , renewing DEA-registered practitioners must complete 8 hours of one-time training on the treatment and management of patients with opioid or substance use disorders. Get the training you need in a self-paced, convenient format with a course specifically designed for physicians to meet the Drug Enforcement Administration (DEA)’s new requirement under the Medication Access and Training Expansion (MATE) Act. Need to complete the DEA’s new requirement under the Medication Access and Training Expansion (MATE) Act?

iii

Powered by